Skip to content
SkimSkim home
In deliveryUnited KingdomGoodsFramework agreement£41,686,538Add to pipeline

NP30925 Psychiatry and Neurology Medicines

Awarded to Accord-UK Ltd, Alturix Ltd, Amarox Limited +33 more

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)(buyer)

Published
Published 23 April 2025
Deadline
Closed 23 May 2025

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

NHS National Services Scotland procured psychiatry and neurology medicines through a framework agreement, with an estimated value of £41.7 million. The contract was awarded in July 2025 to 35 pharmaceutical suppliers including major manufacturers such as GlaxoSmithKline, Pfizer, Novartis, Roche, and Janssen Cilag, with a total award value of £7.0 million. The procurement is now in delivery and complete.

Contracting authority

  • The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

    Buyer

    Edinburgh, United Kingdom

    Authority website ↗

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Lots (2)

  • Carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid

    Supply of carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier framework agreement per product line to seventeen (17) Framework Participants.

    £1,973,036Won by Accord-UK LtdWon by Aventis Pharma Ltd Trading As SanofiWon by Crescent Pharma LimitedWon by CST Pharma LtdWon by Flynn Pharma LtdWon by GlaxoSmithKlineWon by Janssen Cilag LtdWon by Kent Pharmaceuticals LtdWon by Lupin (Europe) LimitedWon by Martindale PharmaWon by Mercury Pharmaceuticals LimitedWon by Necessity Supplies LtdWon by Novartis Pharmaceuticals UK LtdWon by Pfizer LtdWon by SandozWon by Teva UK LtdWon by Wockhardt UK Limited
  • All other psychiatry and neurology medicines

    Supply of other psychiatry and neurology medicines to NHS Scotland. The Authority intends to award the Framework Agreement as a single supplier framework agreement per line to thirty-three (33). Framework Participants.

    £39,713,504Won by Accord-UK LtdWon by Alturix LtdWon by Consilient Health LtdWon by Crescent Pharma LimitedWon by CST Pharma LtdWon by Flynn Pharma LtdWon by Focus Pharmaceuticals LtdWon by Galvany PharmaWon by GlaxoSmithKlineWon by Hikma PharmaceuticalsWon by Janssen Cilag LtdWon by Kent Pharmaceuticals LtdWon by Macure Pharma ApsWon by Martindale PharmaWon by Mercury Pharmaceuticals LimitedWon by MSN LabsWon by Necessity Supplies LtdWon by Neuraxpharm UK LtdWon by Novumgen LimitedWon by Otsuka Pharmaceuticals (UK) LtdWon by Pfizer LtdWon by Ranbaxy (UK) LtdWon by Roche Products LtdWon by ROVI Biotech LimitedWon by SandozWon by SERB SAWon by Teva UK LtdWon by STADA UK - Thornton & RossWon by Wockhardt UK LimitedWon by ZentivaWon by Amarox LimitedWon by Medical ValleyWon by Lundbeck Limited

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£41,686,538
Procedure
Open
Contract type
Framework agreement
Published
23 April 2025
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£7,031,939
Award date
24 July 2025
Contract period
— → 8 July 2028
Winners
  • Accord-UK Ltd
  • Alturix Ltd
  • Amarox Limited
  • Aventis Pharma Ltd Trading As Sanofi
  • CST Pharma Ltd
  • Consilient Health Ltd
  • Crescent Pharma Limited
  • Flynn Pharma Ltd
  • Focus Pharmaceuticals Ltd
  • Galvany Pharma
  • GlaxoSmithKline
  • Hikma Pharmaceuticals
  • Janssen Cilag Ltd
  • Kent Pharmaceuticals Ltd
  • Lundbeck Limited
  • Lupin (Europe) Limited
  • MSN Labs
  • Macure Pharma Aps
  • Martindale Pharma
  • Medical Valley
  • Mercury Pharmaceuticals Limited
  • Necessity Supplies Ltd
  • Neuraxpharm UK Ltd
  • Novartis Pharmaceuticals UK Ltd
  • Novumgen Limited
  • Otsuka Pharmaceuticals (UK) Ltd
  • Pfizer Ltd
  • ROVI Biotech Limited
  • Ranbaxy (UK) Ltd
  • Roche Products Ltd
  • SERB SA
  • STADA UK - Thornton & Ross
  • Sandoz
  • Teva UK Ltd
  • Wockhardt UK Limited
  • Zentiva

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    18 August 2025

  2. Contract Notice

    23 April 2025

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.